Amicogen, Inc. (KOSDAQ:092040)
886.00
-60.00 (-6.34%)
Nov 20, 2026, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 62.42 billion as of November 20, 2026. It is the 30,033rd most valuable company in the world and the 1,536th biggest in South Korea. Its market cap has decreased by 61.83% in one year.
Market Cap
62.42B
Enterprise Value
110.82B
Revenue
48.08B
Global Rank
Country Rank
#1,536 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 62.42B, a decrease of -73.68%. That is a compound annual growth rate of -9.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 62.42B | -36.92% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 130.38B |
| MedPacto | 124.08B |
| HLB Therapeutics | 103.12B |
| Vaxcell-Bio Therapeutics | 82.21B |
| Genexine | 80.68B |
| iNtRON Biotechnology | 75.84B |
| GeneOne Life Science | 48.42B |
| Prestige BioPharma | 44.11B |